DK1641819T3 - Oprensning af HER-2-varianter - Google Patents

Oprensning af HER-2-varianter

Info

Publication number
DK1641819T3
DK1641819T3 DK04738948T DK04738948T DK1641819T3 DK 1641819 T3 DK1641819 T3 DK 1641819T3 DK 04738948 T DK04738948 T DK 04738948T DK 04738948 T DK04738948 T DK 04738948T DK 1641819 T3 DK1641819 T3 DK 1641819T3
Authority
DK
Denmark
Prior art keywords
purification
provides
chromatography
variant
variants
Prior art date
Application number
DK04738948T
Other languages
English (en)
Inventor
Marie Eskling
Klaus Gregorius Nielsen
Original Assignee
Bn Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bn Immunotherapeutics Inc filed Critical Bn Immunotherapeutics Inc
Application granted granted Critical
Publication of DK1641819T3 publication Critical patent/DK1641819T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001102Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103Receptors for growth factors
    • A61K39/001106Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK04738948T 2003-06-25 2004-06-24 Oprensning af HER-2-varianter DK1641819T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48231503P 2003-06-25 2003-06-25
DKPA200300954 2003-06-25
PCT/DK2004/000451 WO2004113377A1 (en) 2003-06-25 2004-06-24 Purification of her-2 variants

Publications (1)

Publication Number Publication Date
DK1641819T3 true DK1641819T3 (da) 2009-08-03

Family

ID=33542436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04738948T DK1641819T3 (da) 2003-06-25 2004-06-24 Oprensning af HER-2-varianter

Country Status (12)

Country Link
EP (2) EP1641819B1 (da)
JP (1) JP4579912B2 (da)
AT (1) ATE429447T1 (da)
AU (1) AU2004249362B2 (da)
CA (1) CA2530233C (da)
DE (1) DE602004020769D1 (da)
DK (1) DK1641819T3 (da)
ES (1) ES2325584T3 (da)
MX (1) MXPA05013389A (da)
NO (1) NO20055948L (da)
NZ (1) NZ544017A (da)
WO (1) WO2004113377A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060033870A (ko) 2003-06-25 2006-04-20 파멕사 에이/에스 Her-2 변이체의 정제
WO2006102901A2 (en) * 2005-03-31 2006-10-05 Pharmexa A/S Immunogenic egfr peptides comprising foreign t cell stimulating epitope
EP2073837B1 (en) * 2006-10-06 2014-06-25 Bavarian Nordic Inc. Recombinant modified vaccinia ankara virus encoding a her-2 antigen in combination with a taxane for use in treating cancer
EP4211468A4 (en) * 2020-09-11 2024-10-09 Glympse Bio Inc DETECTION OF EX VIVO PROTEASE ACTIVITY FOR DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT OF DISEASES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
JP2002526419A (ja) 1998-10-05 2002-08-20 ファーメクサ エイ/エス 治療上のワクチン注射のための新規な方法
CN1201004C (zh) * 1999-01-29 2005-05-11 考丽克萨有限公司 HER-2/neu融合蛋白
WO2003087338A2 (en) * 2002-04-11 2003-10-23 Amgen, Inc. Her-2 receptor tyrosine kinase molecules and uses thereof

Also Published As

Publication number Publication date
JP2007523615A (ja) 2007-08-23
CA2530233A1 (en) 2004-12-29
EP1641819B1 (en) 2009-04-22
NZ544017A (en) 2008-04-30
JP4579912B2 (ja) 2010-11-10
MXPA05013389A (es) 2006-03-17
NO20055948L (no) 2005-12-14
EP1641819A1 (en) 2006-04-05
ATE429447T1 (de) 2009-05-15
EP2090586A1 (en) 2009-08-19
AU2004249362B2 (en) 2011-08-25
CA2530233C (en) 2012-09-11
AU2004249362A1 (en) 2004-12-29
WO2004113377A1 (en) 2004-12-29
DE602004020769D1 (de) 2009-06-04
ES2325584T3 (es) 2009-09-09

Similar Documents

Publication Publication Date Title
NO20071432L (no) Fremgangsmate for konsentrasjon av antistoffer of terapeutiske produkter derav.
WO2003062375A3 (en) Stabilizing polypeptides which have been exposed to urea
AU2003215188A1 (en) Fusion proteins of humanized g250 specific antibodies and uses thereof
WO2002069232A3 (en) Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
CY1113153T1 (el) ΙL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ
WO2008013454A3 (en) Immunogenic compounds and protein mimics
DK1780269T3 (da) Virusrensningsmetoder
DE60139542D1 (de) Methoden zur herstellung humaner monoklonaler antikörper
WO2006041934A3 (en) Methods and compositions for improving recombinant protein production
NO20063478L (no) Noytraliserende epitopebasert vekstfremmende vaksine
DK1373301T3 (da) Reducering af immunogeniciteten af fusionsproteiner
WO2006028936A3 (en) Heteromultimeric molecules
DK1208205T3 (da) Fremgangsmåder til frembringelse af L-aminosyrer ved hjælp af en forögelse af cellulært NADPH
WO2000056901A3 (en) Linear and circular expression elements
WO2007130535A3 (en) Novel protein fusion/tag technology
NO20055948L (no) Rensing av HER-2 varianter
EA200600102A1 (ru) Очистка вариантов her-2
DE602005016857D1 (de) Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten
WO2002077648A3 (en) Pathogenic and commensal vaccine antigens
DE50002865D1 (de) Verfahren zur herstellung von benzofuranonoximen
WO2002063009A8 (en) Lp mammalian proteins; related reagents
WO2022133191A3 (en) Protein compositions and methods for producing and using the same
WO2021158982A3 (en) Targeted translation of rna with crispr-cas13 to enhance protein synthesis
EA200501137A1 (ru) Способ и промежуточные соединения для получения оланзапина
DK1444354T3 (da) Fremgangsmåde til forbedring af effektiviteten af en enzymatisk oprensningsproces